-
Je něco špatně v tomto záznamu ?
Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine
K. Hradská, T. Popková, M. Skořupová, J. Mihályová, T. Jelínek, J. Lančová, N. Schellong, R. Hájek
Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Taylor & Francis Open Access
od 2009-06-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
35547597
DOI
10.2147/cmar.s348923
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: Infectious complications, especially febrile neutropenia, in hemato-oncological patients are associated with considerable morbidity, mortality and expenses. Remote monitoring of physiological functions and thus early detection of adverse events via telemedicine could improve the safety of these high-risk patients and save financial resources by shortening the time-to-antibiotics. Methods: Patients undergoing active cancer treatment in high risk of acquiring severe infection are selected and enrolled in this project. Each patient receives a digital blood pressure monitor, an infrared thermometer and a mobile hub (cell phone). In the comfort of their homes, patients measure their blood pressure/pulse and body temperature regularly or whenever they feel unwell. The obtained data are encrypted and forwarded via the mobile hub to the password-protected portal. The values registered outside the set-up range trigger the alarms, which are immediately sent to the designated physician who can check the portal in real-time from any device with an Internet connection, contact the patient, if need be, and initiate the anti-infective therapy almost instantly after the first symptoms occur. Results: Fifty hemato-oncological patients were recruited between March 1, 2018 and August 1, 2020. Two hundred ninety-seven alarms of body temperature were registered and checked by the physician and patients were contacted in 18.5% of the cases (55/297). Among these 55 events, 13 required medical assistance, which makes it approximately one-quarter of all conducted telephone interventions (23.4%) and neither septic shock nor death due to treatment-related toxicity occurred. Conclusion: Telemedicine seems like a useful tool to improve the safety of high risk hemato-oncological patients when treatment-related infectious complications are concerned.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017223
- 003
- CZ-PrNML
- 005
- 20220720100140.0
- 007
- ta
- 008
- 220718s2022 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/CMAR.S348923 $2 doi
- 035 __
- $a (PubMed)35547597
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Hradská, Katarína $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000316602527
- 245 10
- $a Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine / $c K. Hradská, T. Popková, M. Skořupová, J. Mihályová, T. Jelínek, J. Lančová, N. Schellong, R. Hájek
- 520 9_
- $a Background: Infectious complications, especially febrile neutropenia, in hemato-oncological patients are associated with considerable morbidity, mortality and expenses. Remote monitoring of physiological functions and thus early detection of adverse events via telemedicine could improve the safety of these high-risk patients and save financial resources by shortening the time-to-antibiotics. Methods: Patients undergoing active cancer treatment in high risk of acquiring severe infection are selected and enrolled in this project. Each patient receives a digital blood pressure monitor, an infrared thermometer and a mobile hub (cell phone). In the comfort of their homes, patients measure their blood pressure/pulse and body temperature regularly or whenever they feel unwell. The obtained data are encrypted and forwarded via the mobile hub to the password-protected portal. The values registered outside the set-up range trigger the alarms, which are immediately sent to the designated physician who can check the portal in real-time from any device with an Internet connection, contact the patient, if need be, and initiate the anti-infective therapy almost instantly after the first symptoms occur. Results: Fifty hemato-oncological patients were recruited between March 1, 2018 and August 1, 2020. Two hundred ninety-seven alarms of body temperature were registered and checked by the physician and patients were contacted in 18.5% of the cases (55/297). Among these 55 events, 13 required medical assistance, which makes it approximately one-quarter of all conducted telephone interventions (23.4%) and neither septic shock nor death due to treatment-related toxicity occurred. Conclusion: Telemedicine seems like a useful tool to improve the safety of high risk hemato-oncological patients when treatment-related infectious complications are concerned.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Popková, Tereza $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000158854218
- 700 1_
- $a Skořupová, Michaela $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Mihályová, Jana $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Jelínek, Tomáš $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Lančová, Jana $u National Monitoring Center, Ostrava, Czech Republic
- 700 1_
- $a Schellong, Norbert $u National Monitoring Center, Ostrava, Czech Republic
- 700 1_
- $a Hájek, Roman $u Faculty of Science, University of Ostrava, Ostrava, Czech Republic $u Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 773 0_
- $w MED00165412 $t Cancer management and research $x 1179-1322 $g Roč. 14, č. - (2022), s. 1655-1661
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35547597 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100136 $b ABA008
- 999 __
- $a ind $b bmc $g 1816494 $s 1168465
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 14 $c - $d 1655-1661 $e 20220504 $i 1179-1322 $m Cancer management and research $n Cancer manag. res. $x MED00165412
- LZP __
- $a Pubmed-20220718